Petco Health and [WOOF] vs Arhaus [ARHS] Detailed Stock Comparison
Petco Health and
NASDAQ
Loading...
Arhaus
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Petco Health and wins in 8 metrics, Arhaus wins in 11 metrics, with 0 ties. Arhaus appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Petco Health and | Arhaus | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.43 | 22.44 | Arhaus |
| Price-to-Book Ratio | 0.80 | 4.10 | Petco Health and |
| Debt-to-Equity Ratio | 264.36 | 142.70 | Arhaus |
| PEG Ratio | 52.83 | 24.39 | Arhaus |
| EV/EBITDA | 14.80 | 14.09 | Arhaus |
| Profit Margin (TTM) | -1.10% | 5.33% | Arhaus |
| Operating Margin (TTM) | 1.10% | 13.05% | Arhaus |
| EBITDA Margin (TTM) | 1.10% | 13.05% | Arhaus |
| Return on Equity | -5.90% | 20.48% | Arhaus |
| Return on Assets (TTM) | 0.59% | 4.53% | Arhaus |
| Free Cash Flow (TTM) | $49.68M | $39.74M | Petco Health and |
| 1-Year Return | 36.05% | -11.37% | Petco Health and |
| Price-to-Sales Ratio (TTM) | 0.15 | 1.18 | Petco Health and |
| Enterprise Value | $3.68B | $1.90B | Petco Health and |
| EV/Revenue Ratio | 0.61 | 1.42 | Petco Health and |
| Gross Profit Margin (TTM) | 38.17% | 41.35% | Arhaus |
| Revenue per Share (TTM) | $22 | $10 | Petco Health and |
| Earnings per Share (Diluted) | $-0.24 | $0.50 | Arhaus |
| Beta (Stock Volatility) | 1.72 | 2.55 | Petco Health and |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Petco Health and vs Arhaus Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Petco Health and | 1.28% | 8.56% | 3.26% | 0.00% | 4.97% | -22.68% |
| Arhaus | -6.42% | 29.26% | 22.22% | 41.49% | -12.75% | 19.11% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Petco Health and | 36.05% | -79.91% | -88.56% | -88.56% | -88.56% | -88.56% |
| Arhaus | -11.37% | 40.07% | -8.11% | -8.11% | -8.11% | -8.11% |
Performance & Financial Health Analysis: Petco Health and vs Arhaus
| Metric | WOOF | ARHS |
|---|---|---|
| Market Information | ||
| Market Cap | $884.39M | $1.58B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,716,220 | 2,321,460 |
| 90 Day Avg. Volume | 3,870,527 | 2,186,953 |
| Last Close | $3.17 | $11.22 |
| 52 Week Range | $2.23 - $6.29 | $6.61 - $13.97 |
| % from 52W High | -49.60% | -19.69% |
| All-Time High | $31.08 (Jan 11, 2021) | $19.81 (Jun 03, 2024) |
| % from All-Time High | -89.80% | -43.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.16% |
| Quarterly Earnings Growth | -0.02% | 0.58% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.05% |
| Operating Margin (TTM) | 0.01% | 0.13% |
| Return on Equity (TTM) | -0.06% | 0.20% |
| Debt to Equity (MRQ) | 264.36 | 142.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.98 | $2.74 |
| Cash per Share (MRQ) | $0.48 | $1.67 |
| Operating Cash Flow (TTM) | $170.63M | $144.23M |
| Levered Free Cash Flow (TTM) | $104.90M | $89.64M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Petco Health and vs Arhaus
| Metric | WOOF | ARHS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.43 | 22.44 |
| Forward P/E | 52.83 | 24.39 |
| PEG Ratio | 52.83 | 24.39 |
| Price to Sales (TTM) | 0.15 | 1.18 |
| Price to Book (MRQ) | 0.80 | 4.10 |
| Market Capitalization | ||
| Market Capitalization | $884.39M | $1.58B |
| Enterprise Value | $3.68B | $1.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.61 | 1.42 |
| Enterprise to EBITDA | 14.80 | 14.09 |
| Risk & Other Metrics | ||
| Beta | 1.72 | 2.55 |
| Book Value per Share (MRQ) | $3.98 | $2.74 |
Financial Statements Comparison: Petco Health and vs Arhaus
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WOOF | ARHS |
|---|---|---|
| Revenue/Sales | $1.49B | $311.37M |
| Cost of Goods Sold | $923.43M | $195.79M |
| Gross Profit | $569.97M | $115.59M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $16.36M | $5.53M |
| EBITDA | $67.08M | $27.05M |
| Pre-Tax Income | $-15.78M | $6.08M |
| Income Tax | $495,000 | $1.20M |
| Net Income (Profit) | $-11.66M | $4.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WOOF | ARHS |
|---|---|---|
| Cash & Equivalents | $133.34M | $214.39M |
| Total Current Assets | $920.43M | $552.76M |
| Total Current Liabilities | $1.08B | $437.32M |
| Long-Term Debt | $2.61B | $475.40M |
| Total Shareholders Equity | $1.11B | $348.83M |
| Retained Earnings | $-1.16B | $147.84M |
| Property, Plant & Equipment | $3.58B | $677.81M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WOOF | ARHS |
|---|---|---|
| Operating Cash Flow | $38.31M | $50.00M |
| Capital Expenditures | $-28.41M | $-27.62M |
| Free Cash Flow | $-43.87M | $18.89M |
| Debt Repayment | $-1.14M | $-212,000 |
| Common Stock Repurchase | N/A | $-1.46M |
Short Interest & Institutional Ownership Analysis
| Metric | WOOF | ARHS |
|---|---|---|
| Shares Short | 20.94M | 6.83M |
| Short Ratio | 5.60 | 3.88 |
| Short % of Float | 0.23% | 0.31% |
| Average Daily Volume (10 Day) | 2,716,220 | 2,321,460 |
| Average Daily Volume (90 Day) | 3,870,527 | 2,186,953 |
| Shares Outstanding | 276.89M | 140.63M |
| Float Shares | 87.50M | 51.05M |
| % Held by Insiders | 0.05% | 0.05% |
| % Held by Institutions | 1.29% | 1.12% |
Dividend Analysis & Yield Comparison: Petco Health and vs Arhaus
| Metric | WOOF | ARHS |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.17 |
| 3-Year Avg Dividend Yield | N/A | 3.30% |
| 3-Year Total Dividends | N/A | $0.50 |
| Ex-Dividend Date | N/A | Mar 20, 2024 |